• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Presbyopia compensation with femtosecond laser


This article discusses the advantages and limitations for surgical compensation of presbyopia with the femtosecond laser using corneal inlays and the Intracor technique.

In short: This article discusses the advantages and limitations for surgical compensation of presbyopia with the femtosecond laser using corneal inlays and the Intracor technique.

By 2020, there will be around 2.1 billion presbyopes worldwide.1 It is unsurprising that there is a continuing interest in refractive surgical procedures that improve near vision.

Both surgical interventions for presbyopia, and their contact lens counterparts, may reduce distance acuity, quality of vision, stereopsis or contrast sensitivity. Many also consider clear lens surgery too invasive, particularly in the early stages of the condition. Thus, there is significant interest in corneal inlays as they do not remove tissue; they preserve future options for presbyopic correction; they may be used in pseudophakia and/or combined with laser refractive surgery; they are removable; and they are only implanted within the non-dominant eye.1

Related: Intracorneal inlays for the correction of presbyopia and low hyperopia

There are three different corneal inlay types currently available: refractive optic inlays, which change the eye’s refractive index, providing distance vision through a plano central zone surrounded by one or more rings of varying add power for near vision; corneal reshaping inlays, which reshape the anterior curvature of the cornea to enhance near and intermediate vision via a multifocal effect; and small-aperture inlays, which rely on pinhole optics to increase depth of focus by blocking unfocused light.

Only a small percentage of presbyopes are emmetropic; therefore, an additional LASIK might be performed in the case of a compound refractive error. Femtosecond lasers provide more predictable flap thickness, lower incidence of dry eye, faster visual recovery and better uncorrected distance visual acuity (UDVA) than mechanical microkeratomes.2-4 When a laser flap is created, many nerve-fibre bundles are cut; however, a pocket interface minimises the impact on the corneal nerves.

Corneal reshaping inlays


Corneal reshaping inlays

A clear, permeable hydrogel material makes up the Raindrop Near Vision Inlay (Revision Optics, Lake Forest, California, USA), which has around the same refractive index as the cornea (Figure 1).5 The inlay reshapes the central pupillary region of the non-dominant eye’s cornea to provide additional optical power relative to the unchanged peripheral region.

Combination with myopic LASIK

Twelve-month results of 30 presbyopic patients after inlay implantation combined with myopic LASIK demonstrated that mean binocular UDVA, uncorrected intermediate visual acuity (UIVA) and uncorrected near visual acuity (UNVA) were better than 0.1 logMAR (20/25), and 93% of patients had binocular visual acuities better than 0.1 logMAR across all visual ranges.6

Patient questionnaires also showed that, 1 year after surgery, visual symptoms were at preoperative levels, 98% of all visual tasks could be easily performed without correction and 90% of patients were at least ‘satisfied’ with their overall vision.

Recent news: IOL-related advances increase satisfaction, improve toric outcomes

Combination with hyperopic LASIK

Twelve months after implantation combined with hyperopic LASIK, mean UNVA in the surgical eye (n=16) improved from 0.8 logMAR preoperatively to 0.0 logMAR (patients gained a mean of >7 lines of UNVA).8 The mean binocular gain in UNVA was also seven lines. The UDVA in the surgical eye significantly increased from 0.5 logMAR to 0.2 logMAR and performed even better binocularly. There were no reported visual symptoms.

Refractive optics inlay


Refractive optics inlay

The Flexivue Microlens (Presbia, Los Angeles, CA, USA), based on the InVue lens, is a transparent hydrophilic disk with a central 1.6 mm diameter plano disk and a peripheral zone that provides near addition power. The lens material’s refractive index is 1.4583 and it features a 0.51 mm central hole to facilitate the transfer of oxygen and nutrients to the cornea.10

The Icolens system (Neoptics AG, Huenenberg, Switzerland) comprises a microlens with a positive refractive power, a femtosecond laser (Femto LDV, Ziemer Ophthalmic Systems AG, Port, Switzerland) with pocket-cutting algorithm, preloaded deployment device and purpose-designed positioning instruments. The Icolens is based on a similar design to Flexivue, with a central hole. Its copolymer has hydrogel properties and a refractive index of 1.460 in hydrated conditions.

Short- to mid-term results and biocompatibility

The Flexivue Microlens : Limnopoulou et al. 12 reported a significant increase in monocular and binocular UNVA (n=47). However, it should be noted that UDVA in operated eyes significantly worsened from 0.06 logMAR to 0.38 logMAR, maintaining stable binocular values. The mean refraction changed from 0.66 D to -1.95 D. No complications, removal or replacement occurred.

In a different study, postoperative slitlamp examinations showed clear corneas in 52 patients without evidence of thinning, scarring or vascularisation , with well-centered inlays at all timepoints.10

The Icolens system: Baily et al. 13 reported 12-month results after monocular implantation in emmetropic patients. Mean UNVA in the surgical eye (n=52) improved from 0.78 logMAR to 0.44 logMAR postoperatively, and patients gained a mean of 3.48 lines. The UDVA in the surgical eye significantly worsened (mean loss of 1.67 lines) but, binocularly, could be maintained. In total, 90% of patients reported being satisfied with the overall procedure.

KAMRA inlay highly anticipated in 2016: Find out what else is coming!

Small-aperture inlays

The KAMRA inlay (AcuFocus Inc, Irvine, CA, US) is approved in >50 countries outside the USA, with >20,000 inlays implanted today worldwide. The current generation (model ACI7000PDT) is a 5 μm thin microperforated artificial aperture, with a total diameter of 3.8 mm and a central aperture of 1.6 mm, made of polyvinylidene fluoride with incorporated nanoparticles of carbon. The opaque permeable material has a light transmission of 6.7% and a pseudorandom microperforation pattern (consisting of 8,400 holes); it allows water and nutrient flow.

Long-term results


Long-term results

The longest follow-up to date (5 years; n=32), showed that mean binocular uncorrected visual acuities improved as follows: UNVA from 0.4 logMAR to 0.1 logMAR and UIVA from 0.2 logMAR to 0.1 logMAR.14 The UDVA decreased from -0.2 logMAR to -0.1 logMAR. One inlay was removed after 36 months because the patient was dissatisfied with vision after a hyperopic shift in the surgical eye.

More news: Intracorneal inlays for the correction of presbyopia and low hyperopia

Reading ability

It has been suggested that the ability to perform common daily tasks without glasses may be a better indicator of functional success than actual visual acuity. After 12 months, mean reading distance changed from 46.7 cm to 42.8 cm, and the mean reading acuity “at best distance” improved from 0.33 logRAD (reading equivalent of logMAR) to 0.24 logRAD. Mean reading speed and the smallest readable print size also improved.15

Contrast sensitivity and depth of focus

Vilupuru et al. 17 reported that KAMRA inlay subjects demonstrated improved intermediate and near vision with minimal to no change to distance vision, better contrast sensitivity in the inlay eye when compared with the multifocal lenses, and better binocular contrast sensitivity when compared with accommodating and multifocal IOLs.

Visual simulations of the KAMRA corneal inlay suggest that the device extends depth of focus as effectively as traditional monovision in photopic light, in both cases at the cost of binocular summation.18

Tabernero21 suggested that the best depth of focus in KAMRA patients can be obtained with small residual myopia (-0.75 D to -1.0 D) in the inlay eye and a plano refraction in the fellow eye. The use of a small aperture significantly reduced the negative impact of monovision on stereopsis.

Effect of pupil size and retinal image brightness


Effect of pupil size and retinal image brightness

Tomita et al. 19 reported that pupil size does not influence visual acuity after KAMRA inlay implantation (n=584).

The effect of the KAMRA corneal inlay on the retinal image brightness in the peripheral visual field has also been evaluated by ‘implanting’ a KAMRA inlay into a theoretical eye model in a corneal depth of 200 microns, varying pupil size from 2.0 to 5.0 mm and field angles from -70° to 70°. For large field angles, where the incident ray bundle is passing through the peripheral cornea, brightness is not affected. For combinations of small pupil size (2.0 and 2.5 mm) and field angles of 20–40°, up to 60% of light may be blocked with the KAMRA.20

Corneal inflammation and iron deposition

An early increase in stromal cell death and inflammation was shown 48 hours after surgery in rabbit eyes that underwent a femtosecond laser pocket creation and KAMRA insertion compared with eyes with pocket formation only. The difference disappeared by 6 weeks after surgery.23

Recent news: First three injections predict success of anti-VEGFs in diabetic macular edema

With the first-generation inlay (ACI7000), 18 (56%) eyes of 32 patients developed corneal iron deposition within 36 months after corneal inlay implantation.25 Alterations in tear film thickness, its composition and corneal epithelial basal cell storage, resulting from changes in corneal topography, may be contributing factors. Corneal iron deposition was only observed in 1 of 24 patients after 18 months with the new KAMRA inlay design (ACI7000PDT). Reduced inlay thickness and an increase in the number of nutritional pores as well as the modified implantation technique may contribute to this decrease.26

Combination with hyperopic LASIK

In a recent study by Tomita et al. 27 (n=277) all age-stratified groups achieved a mean UDVA of 0.0 logMAR after simultaneous LASIK and KAMRA implantation. Group 1 (40 to 49 years), Group 2 (50 to 59 years) and Group 3 (60 to 65 years) gained 1 line, 2 lines and 3 lines, respectively, suggesting that taking age into account might help achieve optimum outcomes.

The INTRACOR technique


The INTRACOR technique

The INTRACOR procedure is a minimally invasive intrastromal compensation for presbyopia using a femtosecond laser (FEMTEC Laser System; Bausch+Lomb/Technolas Perfect Vision, Munich Germany).35 The basic pattern for presbyopia is a series of femto-disruptive cylindrical rings that are delivered, starting within the posterior stroma, at a variable distance from Descemet’s membrane, and extending through the mid-stroma to an anterior location at a predetermined, fixed distance beneath Bowman’s layer. Laser delivery does not impact the endothelium, Descemet’s membrane, Bowman’s layer, or epithelium. The net effect is a central steepening of the anterior corneal surface in a multifocal hyperprolate corneal shape.35

More news: Easier ways to identify compromised corneas

The standard pattern consists of five rings,37,38 although it might also be modified by creating six rings or by placing eight additional radial intrastromal cuts in the midperipheral stroma.36,39

Long-term results

The longest follow-up reported 36 month results of 20 presbyopic patients with mild hyperopia (modified pattern with 6 rings).39 Patients were randomly divided into three subgroups to compare the effect of three different ring diameters of the additional placed sixth ring [1.8/2.0/2.2 mm (Groups A/B/C)]. Median UNVA increased from 0.7/0.7/0.7 logMAR (Groups A/B/C) to −0.1/0.1/0.1 logMAR 36 months after surgery. UDVA changed slightly from 0.1/0.2/0.1 logMAR to 0.2/0.3/0.1 logMAR. Loss of two lines of binocular CDVA was noted in 0/25/0% of eyes. Overall patient satisfaction with the procedure was 80%.

Combination with LASIK


Combination with LASIK

Three case reports describe corneal ectasia after combining LASIK with INTRACOR.

  • Saad et al. 42 reported one patient treated bilaterally for hyperopia using LASIK and achieving stable vision. Three years after the last LASIK enhancement, INTRACOR was applied bilaterally. After the procedure, a severe loss in CDVA and in quality of vision occurred, associated with a topography pattern suggestive of isolated anterior central protrusion.

  • Taneri et al. 43 reported a patient receiving unilateral INTRACOR for presbyopia, followed 2 years later by an additional excimer LASIK enhancement (SUPRACOR) on both eyes. The eye treated with INTRACOR followed by SUPRACOR LASIK developed marked ectasia topographically limited to the area altered by INTRACOR, whereas the fellow eye remained stable and still has no signs of ectasia.

  • Courjaret et al. 44 described histopathologic findings in a case of hyperopic LASIK (twice in both eyes) followed by bilateral INTRACOR correction. A deep anterior lamellar keratoplasty had to be performed in one eye, and microscopy of the corneal button revealed that the inner intrastromal incision crossed the LASIK interface and led to stromal bed dehiscence.

Recent news: Trends in U.S. refractive surgery: 2015 ISRS survey

The additive effects on stromal corneal stiffness of the LASIK lamellar incision in the frontal plane and INTRACOR incisions in the sagittal plane may disturb the corneal structural stability and lead to a progressive over-relaxing effect on the residual stromal bed. Therefore, the combination of both procedures can not be recommended.


R.L. Lindstrom et al., Curr. Opin. Ophthalmol. 2013; 24: 281-287.

G.M. Kezirian and K.G. Stonecipher. J. Cataract Refract. Surg. 2004; 30: 804-811.

M.Q. Salomão, R. Ambrósio Jr. and S.E. Wilson. J. Cataract Refract. Surg. 2009; 35: 1756-1760.

M. Tanna, S.C. Schallhorn and K.A. Hettinger. J. Refract. Surg. 2009; 25(7 Suppl): S668-S671.

P.M. Pinsky. Invest. Ophthalmol. Vis. Sci. 2014; 55: 3093-3106.

E.B. Garza and Chayet A. J. Cataract Refract. Surg. 2015; 41: 306-312.

A. Yoo et al., J. Refract. Surg . 2015; 31: 454-460.

A. Chayet and E. Barragan Garza. J. Cataract Refract. Surg. 2013; 39: 1713-1721.

G.D. Parkhurst et al., J. Refract. Surg. 2015; 31: 206-208.

A. Malandrini et al ., J. Cataract Refract. Surg. 2014; 40: 545-557.

D.I. Bouzoukis et al ., J. Refract. Surg. 2011; 27: 818-820.

A.N. Limnopoulou et al ., J. Refract. Surg. 2013; 2: 12-18.

C. Baily, T. Kohnen and M. O’Keefe. J. Cataract Refract. Surg. 2014; 40: 1341-1348.

A.K. Dexl et al ., J. Cataract Refract. Surg. 2015; 41: 566-575.

A.K. Dexl et al ., Am. J. Ophthalmol. 2012; 153: 994-1001.

O. Seyeddain et al ., J. Cataract Refract. Surg . 2013; 39(2): 234-241.

S. Vilupuru, L. Lin and J.S. Pepose. Am. J. Ophthalmol. 2015; 160: 150-162.

C. Schwarz et al ., Biomed. Opt. Express. 2014; 5: 3355-3366.

M. Tomita et al., J. Refract. Surg. 2014; 30: 448-453.

A. Langenbucher et al., Biomed. Res. Int. 2013; 2013: 154593.

J. Tabernero and P. Artal. J. Cataract Refract. Surg. 2012; 38: 270-277.

E.J. Fernández et al ., Biomed. Opt. Express. 2013; 4: 822-830.

M.R. Santhiago et al ., J. Refract. Surg. 2012; 28: 144-149.

A. Abbouda, J. Javaloy and J.L. Alió. J. Refract. Surg. 2014; 30: 172-178.

A.K. Dexl et al . J. Refract. Surg. 2011; 27: 876-880.

A.K. Dexl, O. Seyeddain and G. Grabner. J. Refract. Surg. 2011; 27: 856-857.

M. Tomita and G.O. Waring 4th. J. Cataract Refract. Surg. 2015; 41:152-161.

M. Mita, T. Kanamori and M. Tomita. J. Cataract Refract. Surg. 2013; 39: 1768-1773.

T.E. Tan and J.S. Mehta. Clin. Ophthalmol. 2013; 7: 1899-1903.

M. Inoue et al ., Acta Ophthalmol. 2014; 92: 168-169.

J.L. Alió et al ., J. Refract. Surg. 2013; 29: 550-556.

D. Gatinel et al ., J. Cataract Refract. Surg. 2012; 38: 2186-2191.

C.C. Corpuz et al . J. Cataract Refract. Surg. 2015; 41: 162-170.

P. Casas-Llera, J.M. Ruiz-Moreno and J.L. Alió. J. Cataract Refract. Surg. 2011; 37: 1729-1731.

L.A. Ruiz, L.M. Cepeda and V.C. Fuentes. J. Refract. Surg. 2009; 25: 847-854.

B.C. Thomas et al ., J. Refract. Surg. 2012; 28: 872-878.

M.P. Holzer et al ., J. Refract. Surg. 2009; 25: 855-861.

N. Menassa et al ., J. Cataract Refract. Surg. 2012; 38: 765-773.

R. Khoramnia et al . Br. J. Ophthalmol. 2015; 99: 170-176.

T.M. Rabsilber et al ., J. Cataract Refract. Surg. 2011; 37: 532-537.

A. Fitting A et al ., J. Cataract Refract. Surg. 2012; 38: 1293-1297.

A. Saad, A. Grise-Dulac and D. Gatinel. J. Cataract Refract. Surg. 2010; 36: 1994-1998.

S. Taneri and S. Oehler. J. Refract. Surg. 2013; 29: 573-576.

J.C. Courjaret et al., J. Ref Surg. 2013; 29: 865-868.


Dr Alois K. Dexl MD MSc

e: a.dexl@salk.at

Dr Dexl is Associate Professor at the Department of Ophthalmology of the Paracelsus Medical University of Salzburg. He has no financial or proprietary interest in any material or method mentioned

Related Videos
EyeCon 2024: Peter J. McDonnell, MD, marvels on mentoring, modern technology, and ophthalmology’s future
CIME 2024: Neda Shamie, MD, reports on a morning session packed with refractive surgery options, retina, glaucoma, and a 'mite-y' Demodex discussion
Highlights from the 18th Annual Controversies in Modern Eye Care Symposium: Arjan Hura, MD, on Refractive Surgery, Retina Care, and Record Attendance
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
Arjan Hura, MD, highlights the clinical and surgical updates at CIME 2024
Neda Nikpoor, MD, talks about the Light Adjustable Lens at ASCRS 2024
© 2024 MJH Life Sciences

All rights reserved.